EXPERIMENTAL STUDY OF ALLERGENIC PROPERTIES AND IMMUNOTOXICITY OF THE DRUG STODAL

Allergenicity and immunotoxicity of Stodal preparation was assessed. Immunization of guinea pigs with Stodal in doses of 1 ml/kg and 10 ml/kg according to a standard scheme or mixed with complete Freund’s adjuvant did not provoke a systemic anaphylactic reaction or delayed allergenic reactions in animals. A single per os administration of the Stodal preparation in doses of 1mg/kg and 10 ml/kg to CBA line mice did not affect the inflammation response to concanavalin A (Con.A).

In F₁ (CBA x C57BL/6) mice , Stodal perorally administrated at a dose of 1 ml/mg over 14 days caused a significant increase of thymus mass index and cellularity by 41.5% and in a dose of 10 ml/kg the thymus mass increased by 28.7% . The preparation administrated in the doses of 1 ml/kg and 10 ml/kg did not affect peritoneal macrophage phagocytic activity and indicators of the neutrophils hemi-luminescent response to opsonized zymosan. A two week administration of Stodal preparation in doses of 1 ml/kg and 10 ml/kg to CBA and C57BL/6 strain mice induced a significant stimulation of the humoral immune response. In F₁ (CBA x C57BL/6) hybrid mice , 1 ml/kg dose administration induced an authentic increase of cellular immunity indicators. Thus, the Stodal preparation in the dose range investigated does not produce allergenic responses of non-delayed and delayed types and pseudoallergic reactions, stimulates humoral and cellular immunity and does not produce immune-toxic effect.

1. Krepkova L.V., Bortnikova V.V., Sokol’skaya T.A. Some aspects of the toxicological studies of drug based on medicinal plants. Fundamental’nye issledovaniya. 2013. № 9-2: 256-258 (in Russian).

2. Koroid N.V., Zaplatnikova A.L., Mingalimova G.A., Glukhareva N.S. Community-acquired pneumonia in children: diagnosis and treatment. Trudnyy patsient. 2012; 10 (8): 20-25. (in Russian).

3. Radtsig E.Yu. Cough - defense mechanism and a symptom of respiratory tract infections. Pediatriya. 2009; 88 (5): 112-117. (in Russian).

4. Govekar J.P., Paul V.K., Singh K., Oberai Praveen, Roja Varanasi. Clinical evaluation of homoeopathic therapy in the management of hyperlipoproteinemia. Indian Journal of Research in Homeopathy. 2008. 5 (2): 34-41.

5. Guidelines of pre-clinical studies of drugs, 2012 year. Assessment of allergenic properties of drugs. Part 1. Moscow: Grif i K; 2012; 51- 63 (in Russian).

6. Guidelines of pre-clinical studies of drugs, 2012 year. Assessment of immunotoxicology action of pharmacological substances. Part 1. Moscow: Grif i K; 2012; 626-656 (in Russian).

7. Guidelines of pre-clinical studies of drugs, 2012 year. Preclinical studies immunotropic activity of pharmacological agents. Part 1. Moscow: Grif i K; 2012; 626-656 (in Russian).